Business Medical Dialogues
    • facebook
    • twitter
    Login Register
    • facebook
    • twitter
    Login Register
    • Medical Dialogues
    • Speciality Dialogues
    • Education Dialogues
    • Medical Jobs
    • Medical Matrimony
    • MD Brand Connect
    Business Medical Dialogues
    • News
        • Financial Results
        • Hospitals & Diagnostics
        • IT / Health Venture
        • Implants / Devices
        • Insurance
        • Key Movement
        • Pharmaceuticals
        • Policy
        • Technology
        • pharma-news
    • blog
    LoginRegister
    Business Medical Dialogues
    LoginRegister
    • Home
    • News
      • Financial Results
      • Hospitals & Diagnostics
      • IT / Health Venture
      • Implants / Devices
      • Insurance
      • Key Movement
      • Pharmaceuticals
      • Policy
      • Technology
      • pharma-news
    • blog
    Ruby Khatun Khatun
    Ruby Khatun Khatun
      • Home
      • Ruby Khatun Khatun

      Articles By : Ruby Khatun Khatun

      France fines Johnson and Johnson 29.6 million dollars over painkiller patch

      France fines Johnson and Johnson 29.6 million dollars over painkiller patch

      Ruby Khatun Khatun21 Dec 2017 10:15 AM IST
      PARIS: France's competition authority fined U.S. healthcare group Johnson & Johnson 25 million euros ($29.6 million) on Wednesday after it ruled...
      EasyBuyHealth raises seed funding of  350,000 dollars

      EasyBuyHealth raises seed funding of 350,000 dollars

      Ruby Khatun Khatun21 Dec 2017 10:04 AM IST
      New Delhi: EasyBuyHealth, one of India's healthcare services aggregator has recently completed a successful round of seed funding of USD 350,000 (Rs...
      Gene therapy for rare form of blindness wins US approval

      Gene therapy for rare form of blindness wins US approval

      Ruby Khatun Khatun21 Dec 2017 10:04 AM IST
      WASHINGTON: U.S. health officials on Tuesday approved the nation's first gene therapy for an inherited disease, a treatment that improves the sight of...
      Genetics in personalised medicine is healthcare

      Genetics in personalised medicine is healthcare's current buzz word

      Ruby Khatun Khatun21 Dec 2017 9:45 AM IST
      New Delhi: The current buzz word in healthcare is "personalised medicine". Personalised medicine essentially works on the assumption that a disease...
      Pharma giant Teva resists Israel PM on closure plan

      Pharma giant Teva resists Israel PM on closure plan

      Ruby Khatun Khatun21 Dec 2017 9:30 AM IST
      Jerusalem: Teva, the world's largest generic drug company, refused Tuesday to reconsider a decision to close its Jerusalem plant despite pressure from...
      Over 75 percent of Indian drug import comes from China says pharma body IPCA

      Over 75 percent of Indian drug import comes from China says pharma body IPCA

      Ruby Khatun Khatun21 Dec 2017 9:30 AM IST
      New Delhi: An overwhelming dependence on drug imports and related raw materials from China could prove harmful for the health sector in India in the...
      1,179 Ayush drug manufacturers not compliant with Good Manufacturing Practices: Govt

      1,179 Ayush drug manufacturers not compliant with Good Manufacturing Practices: Govt

      Ruby Khatun Khatun20 Dec 2017 3:58 PM IST
      New Delhi: There are 8,667 licenced Ayurvedic, Siddha, Unani and Homoeopathy (ASU&H) drug manufacturers in the country, out of which 1,179 are...
      Lincoln Pharma gets patent for anti-malarial drug in India

      Lincoln Pharma gets patent for anti-malarial drug in India

      Ruby Khatun Khatun20 Dec 2017 12:02 PM IST
      New Delhi: Lincoln Pharmaceuticals has been awarded a patent for an anti-malarial drug in India, the company said.The patent has been awarded by the...
      Healthcare insurance key for MSME workforce: Report

      Healthcare insurance key for MSME workforce: Report

      Ruby Khatun Khatun20 Dec 2017 10:30 AM IST
      Mumbai: The healthcare insurance industry needs to develop infrastructure and deliver affordable healthcare to the micro, small and medium enterprise...
      China accounts for 66 percent of India

      China accounts for 66 percent of India's bulk drug imports in FY'17

      Ruby Khatun Khatun20 Dec 2017 10:15 AM IST
      New Delhi: India's bulk drug imports from top five countries stood at Rs 18,372.54 crore in 2016-17 with China accounting for 66 percent, Parliament...
      Aerie

      Aerie's glaucoma treatment gets early FDA approval

      Ruby Khatun Khatun20 Dec 2017 10:00 AM IST
      Aerie Pharmaceuticals Inc said on Monday the U.S. Food and Drug Administration approved its eyedrop, Rhopressa, as a treatment for glaucoma, two...
      US employers say CVS-Aetna deal would affect health-benefits decisions: survey

      US employers say CVS-Aetna deal would affect health-benefits decisions: survey

      Ruby Khatun Khatun20 Dec 2017 9:45 AM IST
      NEW YORK: CVS Corp's proposed purchase of Aetna Inc will affect decision-making by a majority of large and mid-size U.S. corporations on employee...
      PrevNext

      Popular Stories

      • Email: info@medicaldialogues.in
      • Phone: 011 - 4372 0751

      Website Last Updated On : 13 Oct 2022 5:14 AM GMT
      Company
      • About Us
      • Contact Us
      • Our Team
      • Reach our Editor
      • Feedback
      • Submit Article
      Ads & Legal
      • Advertise
      • Advertise Policy
      • Terms and Conditions
      • Privacy Policy
      • Editorial Policy
      • Comments Policy
      • Disclamier
      Medical Dialogues is health news portal designed to update medical and healthcare professionals but does not limit/block other interested parties from accessing our general health content. The health content on Medical Dialogues and its subdomains is created and/or edited by our expert team, that includes doctors, healthcare researchers and scientific writers, who review all medical information to keep them in line with the latest evidence-based medical information and accepted health guidelines by established medical organisations of the world.

      Any content/information on this website does not replace the advice of medical and/or health professionals and should not be construed as medical/diagnostic advice/endorsement or prescription.Use of this site is subject to our terms of use, privacy policy, advertisement policy. You can check out disclaimers here. © 2025 Minerva Medical Treatment Pvt Ltd

      © 2025 - Medical Dialogues. All Rights Reserved.
      Powered By: Hocalwire
      X
      We use cookies for analytics, advertising and to improve our site. You agree to our use of cookies by continuing to use our site. To know more, see our Cookie Policy and Cookie Settings.Ok